[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Fri, 19 Jan 2007 06:05:52 +0480
No more bankrupts or bad companies.
Look at charts and ask your broker about:
Ventana Medical Systems
Ventana Receives FDA Approval on Pathway
Thursday January 18, 10:08 am ET
Ventana Medical Systems Receives FDA Approval for Breast Cancer Detection Test
TUCSON, Ariz. (AP) -- Ventana Medical Systems Inc., a maker of tissue and slide
preparation systems used in drug development, said Wednesday it received Food
and Drug Administration approval on a new antibody.
The company received the approval for its Pathway Her-2/neu (4B5) Rabbit
Monoclonal Antibody as an aid in assessing breast cancer patients being
considered for treatment with Herceptin. It is also approved for use on the
Ventana Image Analysis System.
Herceptin is a cancer treatment made by Genentech Inc. It targets HER-2, which
causes breast cancer cells to grow more rapidly. The approved Pathway antibody
is intended to detect the presence of the HER-2 antigen.
Get in before most investors hear about this awesome news! VMSI has just made
an announcement which, once the investment community hears about it, is going
to send the issue flying! Read on to find why we are so excited!